Dublin, Feb. 22, 2024 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to ResearchAndMarkets.com's offering.
The realm of molecular diagnostics at the point of care is poised for unprecedented growth and innovation. A new research publication, offering an exhaustive analysis of this dynamic sector, has been added to our extensive database, providing critical data to stakeholders and industry leaders.
Molecular diagnostics has become a critical component in the management of infectious diseases. With advancements in technology, there has been a notable expansion of these services at the point of care. The latest study offers a detailed view of the application, technology, and product landscape, dissecting the current trends and forecasting developments through 2027.
The integration of point of care testing (POCT) and molecular diagnostics is a significant trend altering the diagnostic industry's trajectory. The report sheds light on the role of POCT in enhancing patient outcomes, reducing healthcare costs, and even aiding in the fight against antimicrobial resistance. The detailed analysis encompasses various settings, from hospitals to physicians' offices and potentially patients' homes, offering stakeholders a comprehensive look at the shifting diagnostic paradigms.
Key Highlights from the Report
- Extensive market forecasting, providing a five-year outlook on the industry’s growth.
- In-depth coverage of technology advancements and their implications on current and future market dynamics.
- Analysis of the significant role that POCT plays in transforming frontline test protocols, while simultaneously offering cost-saving benefits.
- Exploration of market trends driven by the convergence of POCT and molecular diagnostic technologies.
- Discussion of strategic shifts in diagnostic procedures with the potential to revolutionize patient care delivery.
Providing insights into the merging trends of molecular diagnostics and point of care testing, the publication emerges as a vital tool for healthcare decision-makers. The research further delves into the part diagnostics may play in not only supplementing physician's diagnostics but revolutionizing entire care strategies. With meticulous data examination and projections, this report will serve as a critical resource for those looking to understand the rapidly evolving landscape of molecular diagnostics at the point of care.
As the healthcare industry continues to embrace the fast-paced growth of molecular diagnostics at the point of care, this authoritative analysis serves as both a current snapshot and forward-looking compass for professionals navigating this market.
Key Topics Covered:
- Market Guides
- Strategic Situation Analysis
- Guides for Executives, Marketing, and Business Development Staff
- Guides for Management Consultants and Investment Advisors
- Market Introduction and Definition
- Understanding Molecular Diagnostics at the Point of Care
- The Diagnostics Revolution
- Defining Market Parameters and Methodology
- Healthcare Perspective and Industry Insights
- Instrumentation, Automation, and Trends
- Analysis of Diagnostic Instrumentation and Automation
- Trends Shaping the Diagnostic Landscape
- Impact of New Technologies on Market Dynamics
- Industry Overview
- Overview of Key Players in the Market
- Market Segmentation and Structure
- Insight into Clinical Laboratory Market Segments
- Market Trends
- Factors Driving and Limiting Market Growth
- Recent Developments in Infectious Disease Molecular Diagnostics
- Global Market Analysis
- Overview of MDx Markets at the Point of Care
- Analysis by Application, Technology, Place, and Product
Companies Mentioned
- Abacus Diagnostica
- Abbott Laboratories
- Accelerate Diagnostics
- Access Bio
- Ador Diagnostics
- ADT Biotech
- Akonni Biosystems
- Alveo Technologies
- Anitoa
- Antelope Dx
- Applied BioCode
- Aureum Diagnostics
- Aus Diagnostics
- Autonomous Medical Devices
- Baebies
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- BioFire Diagnostics (bioMérieux)
- bioMérieux Diagnostics
- Bio-Rad Laboratories, Inc.
- Bosch Healthcare Solutions GmbH
- Cepheid (Danaher)
- Credo Diagnostics Biomedical
- Cue Health
- Curetis N.V./Curetis GmbH
- Detect
- Diagenode Diagnostics
- Diasorin S.p.A.
- Domus Diagnostics
- Enzo Biochem
- Eurofins Scientific
- Fluxergy
- Fusion Genomics.
- Genedrive
- Genetic Signatures
- GenMark Dx (Roche)
- Genomadix
- Getlabs
- Grip Molecular Technologies
- Hibergene Diagnostics
- Hologic
- Immunexpress
- Inflammatix
- Invetech
- Iollo
- Janssen Diagnostics
- Karius
- LightDeck Diagnostics
- Lucira Health
- Luminex Corp (DiaSorin)
- LumiraDx
- Maxim Biomedical
- Meridian Bioscience
- Mesa Biotech (Thermo Fisher)
- MicroGem
- Millipore Sigma
- Minute Molecular
- Mobidiag (Hologic)
- Molbio Diagnostics
- NanoDx
- Nanomix
- Novacyt
- Novel Microdevices
- OnsiteGene
- Operon
- Oxford Nanopore Technologies
- Panagene
- Perkin Elmer
- Prenetics
- Primerdesign (Novacyt)
- Prominex
- Proof Diagnostics
- Qiagen
- QuantuMDx
- QuidelOrtho
- Roche Molecular Diagnostics
- Salignostics
- Saw Diagnostics
- SD Biosensor
- Seegene
- Siemens Healthineers
- Sona Nanotech
- SpeeDx
- T2 Biosystems
- Talis Biomedical
- Thermo Fisher Scientific Inc.
- Veramarx
- XCR Diagnostics
- Zhejiang Orient Gene Biotech
For more information about this report visit https://www.researchandmarkets.com/r/ouxb8t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
